Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-533.87%
operating margin TTM
-524.67%
revenue TTM
6.30 Billion
revenue per share TTM
137.59$
valuation ratios | |
|---|---|
| pe ratio | -0.84 |
| peg ratio | 0.00 |
| price to book ratio | -11.71 |
| price to sales ratio | 3.67 |
| enterprise value multiple | -0.71 |
| price fair value | -11.71 |
profitability ratios | |
|---|---|
| gross profit margin | 73.7% |
| operating profit margin | -524.67% |
| pretax profit margin | -530.88% |
| net profit margin | -533.87% |
| return on assets | -322.33% |
| return on equity | -937.62% |
| return on capital employed | 1045.63% |
liquidity ratios | |
|---|---|
| current ratio | 0.75 |
| quick ratio | 0.69 |
| cash ratio | 0.39 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 158.06 |
| operating cycle | 205.66 |
| days of payables outstanding | 0.00 |
| cash conversion cycle | 205.66 |
| receivables turnover | 7.67 |
| payables turnover | 0.00 |
| inventory turnover | 2.31 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.44 |
| debt equity ratio | -1.43 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 3.33 |
| interest coverage | -102.81 |
| cash flow to debt ratio | 0.00 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.00 |
| cash per share | 12.72 |
| operating cash flow per share | 0.00 |
| free cash flow operating cash flow ratio | 0.00 |
| cash flow coverage ratios | 0.00 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time SymBio Pharmaceuticals Limited (PNK:SYMQY) reported earnings?
SymBio Pharmaceuticals Limited (SYMQY) published its most recent earnings results on 30-06-2026.
What is SymBio Pharmaceuticals Limited's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. SymBio Pharmaceuticals Limited (PNK:SYMQY)'s trailing twelve months ROE is -937.62%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. SymBio Pharmaceuticals Limited (SYMQY) currently has a ROA of -322.33%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did SYMQY's net profit margin stand at?
SYMQY reported a profit margin of -533.87% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is SYMQY's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.75 in the most recent quarter. The quick ratio stood at 0.69, with a Debt/Eq ratio of -1.43.